» Articles » PMID: 12721514

In Vivo Noninvasive Imaging for Gene Therapy

Overview
Specialty Biology
Date 2003 May 2
PMID 12721514
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Gene therapy is reaching a stage where some clinical benefits have been demonstrated on patients involved in phase I/II clinical trials. However, in many cases, the clinical benefit is hardly measurable and progress in the improvement of gene therapy formulations is hampered by the lack of objective clinical endpoints to measure transgene delivery and to quantitate transgene expression. However, these endpoints rely almost exclusively on the analysis of biopsies by molecular and histopathological methods. These methods provide only a limited picture of the situation. Therefore, there is a need for a technology that would allow precise, spacio-temporal measurement of gene expression on a whole body scale upon administration of the gene delivery vector. In the field of gene therapy, a considerable effort is being invested in the development of noninvasive imaging of gene expression and this review presents the various strategies currently being developed.

Citing Articles

Synthesis of Radioiodinated Compounds. Classical Approaches and Achievements of Recent Years.

Petrov S, Yusubov M, Beloglazkina E, Nenajdenko V Int J Mol Sci. 2022; 23(22).

PMID: 36430267 PMC: 9698107. DOI: 10.3390/ijms232213789.


Theranostic nanoparticles for the management of thrombosis.

Russell P, Hagemeyer C, Esser L, Voelcker N Theranostics. 2022; 12(6):2773-2800.

PMID: 35401833 PMC: 8965493. DOI: 10.7150/thno.70001.


Theranostic potential of oncolytic vaccinia virus.

Rojas J, Thorne S Theranostics. 2012; 2(4):363-73.

PMID: 22509200 PMC: 3326721. DOI: 10.7150/thno.3724.


Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.

Merron A, Baril P, Martin-Duque P, De la Vieja A, Tran L, Briat A Eur J Nucl Med Mol Imaging. 2010; 37(7):1377-85.

PMID: 20140612 DOI: 10.1007/s00259-009-1379-3.


Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.

Baril P, Martin-Duque P, Vassaux G Br J Pharmacol. 2009; 159(4):761-71.

PMID: 19814733 PMC: 2829202. DOI: 10.1111/j.1476-5381.2009.00412.x.

References
1.
Boland A, Ricard M, Opolon P, Bidart J, Yeh P, Filetti S . Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res. 2000; 60(13):3484-92. View

2.
Groot-Wassink T, Aboagye E, Glaser M, Lemoine N, Vassaux G . Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther. 2002; 13(14):1723-35. DOI: 10.1089/104303402760293565. View

3.
Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T . Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Endocrinology. 1997; 138(10):4493-6. DOI: 10.1210/endo.138.10.5571. View

4.
Jacobs R, Fraser S . Magnetic resonance microscopy of embryonic cell lineages and movements. Science. 1994; 263(5147):681-4. DOI: 10.1126/science.7508143. View

5.
Brix G, Bellemann M, Haberkorn U, Gerlach L, Lorenz W . Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: a comparative animal study. Nucl Med Biol. 1996; 23(7):897-906. DOI: 10.1016/s0969-8051(96)00122-9. View